Table 5.
Clinical characteristics of the patients at the time of synovectomy/sampling.
| Rheumatoid | Osteoarthritis | ||
| Arthritis (RA) | (OA) | ||
| Patients (n) | 3 | 3 | |
| Sample name | RA1, RA2, RA3, | OA1, OA2, OA3 | |
| Gender (female/male) | 3/0 | 1/2 | |
| Age (years ± SEM) | 62.4 ± 2.9 | 58.7 ± 2.0 | |
| Disease duration (years ± SEM) | 11.5 ± 0.5 | 4.4 ± 0.6 | |
| Rheumatic factor (positive/negative) | 3/0 | 0/3 | |
| ESR1 (mm/h ± SEM) | 26.7 ± 6.2 | 20.0 ± 4.0 | |
| CRP2 (mg/l ± SEM) | 38.1 ± 7.2 | 13.2 ± 2.9 | |
| ARA3 – Criteria for RA (n ± SEM) | 6.0 ± 1.1 | 0.3 ± 0.1 | |
| Concomitant | MTX4 (n) | 1 | 0 |
| medication | NSAIDs5 (n) | 3 | 3 |
1 Erythrocyte sedimentation rate
2 C-reactive protein, normal range: < 5 mg/l
3 American Rheumatism Association (now: American College of Rheumatology)
4 Methotrexate
5 Non steroidal anti-inflammatory drugs